HAE
Haemonetics Corporation
108.40$
+0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 52.3% | 55.3% | 57.3% | 54.4% | 56.8% | 50.6% | 50.8% | 46.6% | 46.7% | 45.6% | 42.8% | 44.3% | |
| 47.7% | 44.7% | 42.7% | 45.6% | 43.2% | 49.4% | 49.2% | 53.4% | 53.3% | 54.4% | 57.2% | 55.7% | |
| 6.0% | 6.1% | 5.3% | 4.3% | 3.7% | 4.0% | 4.7% | 5.6% | 5.0% | 4.8% | 5.1% | 4.5% | |
| 28.4% | 34.5% | 33.8% | 34.7% | 30.4% | 26.5% | 30.0% | 33.0% | 31.4% | 31.6% | 30.4% | 33.2% | |
| 43.3% | 49.5% | 44.9% | 39.4% | 34.5% | 38.9% | 38.9% | 45.3% | 39.9% | 41.8% | 40.9% | 37.6% | |
| 4.5% | -4.8% | -2.2% | 6.2% | 8.6% | 10.5% | 10.3% | 8.1% | 13.4% | 12.6% | 16.3% | 18.1% | |
| 1.0% | 1.0% | 0.9% | 0.5% | 1.0% | 1.6% | 1.9% | 1.7% | 1.3% | 1.0% | 0.7% | 2.2% | |
| 3.4% | -5.9% | -3.1% | 6.6% | 7.6% | 8.8% | 8.4% | 6.4% | 12.1% | 11.6% | 15.6% | 9.6% | |
| 1.6% | 0.2% | -0.1% | 1.6% | 1.9% | 1.1% | -0.8% | 2.0% | 2.2% | 2.6% | 3.3% | 2.3% | |
| 1.9% | -6.1% | -3.0% | 5.0% | 5.7% | 7.7% | 9.1% | 4.4% | 9.9% | 9.0% | 12.3% | 7.3% | |
| 13.9% | 14.2% | 13.9% | 16.9% | 19.9% | 26.1% | 21.2% | 19.3% | 21.6% | 22.6% | 26.2% | 23.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.